Table 3. pEC50 and Imax values of ACh, acetamiprid, and imidacloprid for wild-type, T77R, and T77R+E79V Dα2β2 nAChRs.
| Compounds | Dα2β2 WT | Dα2β2 T77R | Dα2β2 T77R+E79V | |||
|---|---|---|---|---|---|---|
| pEC50 | Imax | |||||
| Ach | 4.60±0.04 | 1.08±0.03 | 4.64±0.07 | 1.03±0.01 | 4.47±0.03 | 1.04±0.02 |
| Acetamiprid | 5.26±0.09 | 0.49±0.03 | 5.42±0.06 | 0.99±0.04* | 5.38±0.04 | 0.97±0.03* |
| Imidacloprid | 5.61±0.06 | 0.77±0.03 | 6.35±0.06* | 0.79±0.03 | 6.18±0.02* | 0.96±0.02* |
Values shown are the results of a fit of the concentration–response data (mean±S.E.M., n=4). Statistical test (one-way ANOVA, Dunnett’s multiple-comparison test) is for significant differences from the wild-type data. * p<0.05. The peak amplitude of the current recorded in the response to each challenge was normalized to the maximum amplitude of the response to ACh. Data from the Dα2β2, T77R, and T77R+E79V mutants were normalized to the response to 1 mM ACh.